Literature DB >> 21802413

Alterations in microRNA expression profile in HCV-infected hepatoma cells: involvement of miR-491 in regulation of HCV replication via the PI3 kinase/Akt pathway.

Hisashi Ishida1, Tomohide Tatsumi, Atsushi Hosui, Takatoshi Nawa, Takahiro Kodama, Satoshi Shimizu, Hayato Hikita, Naoki Hiramatsu, Tatsuya Kanto, Norio Hayashi, Tetsuo Takehara.   

Abstract

The aim of this study was to investigate the role of microRNA (miRNA) on hepatitis C virus (HCV) replication in hepatoma cells. Using miRNA array analysis, miR-192/miR-215, miR-194, miR-320, and miR-491 were identified as miRNAs whose expression levels were altered by HCV infection. Among them, miR-192/miR-215 and miR-491 were capable of enhancing replication of the HCV replicon as well as HCV itself. HCV IRES activity or cell proliferation was not increased by forced expression of miR-192/miR-215 or miR-491. Investigation of signaling pathways revealed that miR-491 specifically suppressed the phosphoinositol-3 (PI3) kinase/Akt pathway. Under inhibition of PI3 kinase by LY294002, the suppressive effect of miR-491 on HCV replication was abolished, indicating that suppression of HCV replication by miR-491 was dependent on the PI3 kinase/Akt pathway. miRNAs altered by HCV infection would then affect HCV replication, which implies a complicated mechanism for regulating HCV replication. HCV-induced miRNA may be involved in changes in cellular properties including hepatocarcinogenesis.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21802413     DOI: 10.1016/j.bbrc.2011.07.049

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  48 in total

1.  Serum microRNAs; miR-30c-5p, miR-223-3p, miR-302c-3p and miR-17-5p could be used as novel non-invasive biomarkers for HCV-positive cirrhosis and hepatocellular carcinoma.

Authors:  Zehra Oksuz; Mehmet Sami Serin; Engin Kaplan; Aylin Dogen; Seda Tezcan; Gonul Aslan; Gurol Emekdas; Orhan Sezgin; Engin Altintas; Eyup Naci Tiftik
Journal:  Mol Biol Rep       Date:  2014-11-13       Impact factor: 2.316

Review 2.  Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation.

Authors:  Zdenko Herceg; Marie-Pierre Lambert; Karin van Veldhoven; Christiana Demetriou; Paolo Vineis; Martyn T Smith; Kurt Straif; Christopher P Wild
Journal:  Carcinogenesis       Date:  2013-06-07       Impact factor: 4.944

3.  Hepatitis C virus infection stimulates transforming growth factor-β1 expression through up-regulating miR-192.

Authors:  Ji Hyun Kim; Chang Ho Lee; Seong-Wook Lee
Journal:  J Microbiol       Date:  2016-06-28       Impact factor: 3.422

4.  Comparative analysis of hepatic miRNA levels in male marathon mice reveals a link between obesity and endurance exercise capacities.

Authors:  Daniela Ohde; Julia Brenmoehl; Christina Walz; Armin Tuchscherer; Elisa Wirthgen; Andreas Hoeflich
Journal:  J Comp Physiol B       Date:  2016-06-09       Impact factor: 2.200

Review 5.  MicroRNA and hepatitis C virus--challenges in investigation and translation: a review of the literature.

Authors:  Paul Ravi Waldron; Mark Holodniy
Journal:  Diagn Microbiol Infect Dis       Date:  2014-06-05       Impact factor: 2.803

6.  MicroRNAs in Liver Disease: Bench to Bedside.

Authors:  Nihar Shah; James E Nelson; Kris V Kowdley
Journal:  J Clin Exp Hepatol       Date:  2013-09-17

Review 7.  Landscape of post-transcriptional gene regulation during hepatitis C virus infection.

Authors:  Johannes Schwerk; Abigail P Jarret; Rochelle C Joslyn; Ram Savan
Journal:  Curr Opin Virol       Date:  2015-04-15       Impact factor: 7.090

8.  Hepatitis C virus inhibits AKT-tuberous sclerosis complex (TSC), the mechanistic target of rapamycin (MTOR) pathway, through endoplasmic reticulum stress to induce autophagy.

Authors:  He Huang; Rongyan Kang; Ji Wang; Guangxiang Luo; Wei Yang; Zhendong Zhao
Journal:  Autophagy       Date:  2012-11-20       Impact factor: 16.016

9.  MicroRNA Signatures for circulating CD133-positive cells in hepatocellular carcinoma with HCV infection.

Authors:  Abdel-Rahman N Zekri; Enas Reda El-Sisi; Amira Salah El-Din Youssef; Mahmoud M Kamel; Auhood Nassar; Ola Sayed Ahmed; Mohamed El Kassas; Ahmed Barakat Barakat; Alaa Ismail Abd El-Motaleb; Abeer A Bahnassy
Journal:  PLoS One       Date:  2018-03-13       Impact factor: 3.240

Review 10.  MicroRNA expression in hepatitis C virus-related malignancies: A brief review.

Authors:  Laura Gragnani; Alessia Piluso; Elisa Fognani; Anna Linda Zignego
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.